The stock of Sana Biotechnology Inc (NASDAQ:SANA) last traded at $1.50, down -10.71% from the previous session.
SANA stock price is now -45.30% away from the 50-day moving average and -60.47% away from the 200-day moving average. The market capitalization of the company currently stands at $337.54M.
With the price target maintained at $5, Citizens JMP recently Upgraded its rating from Mkt Perform to Mkt Outperform for Sana Biotechnology Inc (NASDAQ: SANA). On March 14, 2025, Jefferies recently initiated its ‘Buy’ rating on the stock quoting a target price of $7, while ‘TD Cowen’ rates the stock as ‘Buy’
In other news, CHRISTIAN HORDO & KATHARINE HO, Officer bought 75,000 shares of the company’s stock on Feb 18 ’25. The stock was bought for $237,000 at an average price of $3.16. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 16 ’25, Officer CHRISTIAN HORDO & KATHARINE HO bought 75,000 shares of the business’s stock. A total of $289,500 was incurred on buying the stock at an average price of $3.86. A total of 44.38% of the company’s stock is owned by insiders.
During the past 12 months, Sana Biotechnology Inc has had a low of $1.52 and a high of $10.50. As of last week, the company has a debt-to-equity ratio of 0.38, a current ratio of 3.54, and a quick ratio of 3.54. The fifty day moving average price for SANA is $2.7421 and a two-hundred day moving average price translates $3.7948 for the stock.
The latest earnings results from Sana Biotechnology Inc (NASDAQ: SANA) was released for 2024-12-31.
